Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine

Michail Vikelis1 Glyfada Headache Center, Glyfada, GreeceCorrespondence[email protected]

Dimos D Mitsikostas2 Neurology Department, Athens Naval Hospital, Athens, Greece

Alan M Rapoport3 The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Pages 429-434 | Published online: 26 Sep 2012

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SilbersteinSDMigraine symptoms: results of a survey of self-reported migraineursHeadache19953573873967672955
PubMed Web of Science ®Google Scholar
StovnerLjHagenKJensenRThe global burden of headache: a documentation of headache prevalence and disability worldwideCephalalgia200727319321017381554
PubMed Web of Science ®Google Scholar
Headache Classification Subcommittee of the International Headache SocietyThe international classification of headache disorders: 2nd editionCephalalgia200424Suppl 1916014979299
PubMed Web of Science ®Google Scholar
MenkenMMunsatTLTooleJFThe global burden of disease study: implications for neurologyArch Neurol200057341842010714674
PubMed Web of Science ®Google Scholar
HawkinsKWangSRupnowMDirect cost burden among insured US employees with migraineHeadache200848455356318070057
PubMed Web of Science ®Google Scholar
HawkinsKWangSRupnowMFIndirect cost burden of migraine in the United StatesJ Occup Environ Med200749436837417426520
PubMed Web of Science ®Google Scholar
VikelisMRapoportAMNew drug delivery options for migraineExpert Rev Neurother201111677177321651323
PubMed Web of Science ®Google Scholar
KelmanLTanisDThe relationship between migraine pain and other associated symptomsCephalalgia200626554855316674763
PubMed Web of Science ®Google Scholar
BursteinRCollinsBJakubowskiMDefeating migraine pain with triptans: a race against the development of cutaneous allodyniaAnn Neurol2004551192614705108
PubMed Web of Science ®Google Scholar
BursteinRLevyDJakubowskiMEffects of sensitization of trigemi-novascular neurons to triptan therapy during migraineRev Neurol (Paris)20051616–765866016141951
PubMed Web of Science ®Google Scholar
FuseauEPetricoulOMooreKHPBarrowAIbbotsonTClinical pharmacokinetics of intranasal sumatriptanClin Pharmacokinet2002411180181112190330
PubMed Web of Science ®Google Scholar
UemuraNOnishiTMitaniyamaABioequivalence and rapid absorption of zolmitriptan nasal spray compared with oral tablets in healthy Japanese subjectsClin Drug Investig2005253199208
Web of Science ®Google Scholar
RapoportAMFreitagFPearlmanSHInnovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraineCNS Drugs2010241192994020932065
PubMed Web of Science ®Google Scholar
TepperSJMillsonDSafety profile of the triptansExpert Opin Drug Saf20032212313212904112
PubMedGoogle Scholar
PierceMWHeadache reliefDrug Discovery and Development [internet]. March 1, 2008. Available from: http://www.dddmag.com/Article-Anti-migraine-Drugs-Feature-New-Delivery-Methods.aspx. Accessed May 11, 2012.
Google Scholar
SiegelSJO’NeillCDubéLMA unique iontophoretic patch for optimal transdermal delivery of sumatriptan succinatePharm Res200724101919192617577644
PubMed Web of Science ®Google Scholar
PierceMMarburyTO’NeillCSiegelSDuWSebreeTZelrix: a novel transdermal formulation of sumatriptanHeadache200949681782519438727
PubMed Web of Science ®Google Scholar
GoldsteinJPugachNSmithTAcute anti-migraine efficacy and tolerability of Zelrix, a novel iontophoretic transdermal patch of sumatriptanResearch abstract presented at 14th International Headache CongressSeptember 10–13, 2009Philadelphia (PA)Headache201050350951520456145
PubMedGoogle Scholar
GoldsteinJPugachNSmithTRAcute anti-migraine efficacy and tolerability of Zelrix, a novel iontophoretic transdermal patch of sumatriptanCephalalgia200929Suppl 120
Google Scholar
GoldsteinJSmithTRPugachNA Sumatriptan iontophoretic transdermal system for the acute treatment of migraineHeadache [epub ahead of print].
Web of Science ®Google Scholar
SmithTPierceMWGriesserJLong-term safety and efficacy of NP101, a sumatriptan iontophoretic patch for the treatment of acute migraineHeadache20125261262422352764
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date